Skip to main content

Table 2 Patient and SPL characteristics and outcomes of EUS-FNAB in UR SPL patients

From: Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions

  FNB, UR (N = 22) FNA, UR (N = 36) P value
Age, y, median (range) 68 (49–91) 70 (38–84) 0.79
Sex, male/female 15/7 21/15 0.58
Final diagnosis    0.52
 Pancreatic cancer 22 34  
 Pancreatic neuroendocrine tumor   2  
SPL size, mm, median (range) 30 (15–50) 30 (10–82) 0.70
SPL location, head/body or tail 8/14 14/22 1.0
Puncture route, gastric/duodenal 16/6 26/10 1.0
Puncture number, median (range) 3 (2–5) 4 (1–8) 0.036
Histological specimen, n (%) 22 (100) 26 (72.2) < 0.01
Adverse events, n (%) 0 (0) 1 (2.8) 1.0
 Bleeding, n   1  
  1. SPL Solid pancreatic lesion, UR unresectable
\